Eargo, Competitors

Delisted . USA . 
Stock . Eargo, Inc
EARDelisted Stock  USD 4.00  0.10  2.44%   
Eargo, Inc competes with Neuropace, Inogen, SurModics, Pulmonx Corp, and Apyx Medical; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing Eargo, competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eargo, to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Eargo, competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
4.004.004.00
Details
Intrinsic
Valuation
LowRealHigh
3.723.724.40
Details
Naive
Forecast
LowNextHigh
4.144.144.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.954.354.76
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eargo,. Your research has to be compared to or analyzed against Eargo,'s peers to derive any actionable benefits. When done correctly, Eargo,'s competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eargo, Inc.

Eargo, Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eargo, and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Eargo, and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eargo, Inc does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CVRX
+ 0.9
LUCD
LUCD
+ 0.77
ELMD
HSKA
+ 0.77
ELMD
CVRX
+ 0.72
ELMD
KIDS
+ 0.71
INGN
SRDX
+ 0.67
INGN
  
High negative correlations   
HSKA
- 0.87
INGN
HSKA
- 0.82
KIDS
KIDS
- 0.74
ELMD
ELMD
- 0.63
INGN
ELMD
- 0.52
LUNG
HSKA
- 0.52
SRDX

Risk-Adjusted Indicators

There is a big difference between Eargo, Stock performing well and Eargo, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eargo,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NPCE  3.46  0.18  0.10  0.20  3.15 
(4.25)
 9.73 
(6.19)
 35.38 
INGN  1.95 (0.54) 0.00 (0.32) 0.00 
 0.00 
 3.57 
(4.81)
 22.50 
SRDX  0.48 (0.05)(0.21)(0.02) 0.59 
(0.51)
 1.26 
(1.01)
 3.22 
LUNG  3.16 (0.41) 0.00 (0.10) 0.00 
 0.00 
 8.44 
(6.89)
 20.44 
APYX  3.24  0.18  0.05  0.31  3.31 
(4.26)
 9.38 
(6.45)
 32.02 
ELMD  2.50  0.99  0.36  1.07  1.92 
(3.06)
 6.65 
(3.90)
 13.47 
LUCD  2.21  0.28  0.07  1.05  2.30 
(2.75)
 5.13 
(4.04)
 12.93 
KIDS  2.45 (0.41) 0.00 (0.23) 0.00 
 0.00 
 4.85 
(5.08)
 16.62 
CVRX  3.88  0.74  0.16  1.49  3.55 
(4.87)
 10.68 
(8.22)
 41.08 
HSKA  1.18  0.62  0.82 (3.21) 0.00 
(1.25)
 3.63 
(0.71)
 21.36 
All Fundamental Data

Eargo, Competitive Analysis

The better you understand Eargo, competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eargo,'s competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eargo,'s competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
EAR NPCE INGN SRDX LUNG APYX ELMD LUCD KIDS CVRX
 2.44 
 4.00 
Eargo,
 0.49 
 10.25 
Neuropace
 0.31 
 9.63 
Inogen
 0.10 
 39.54 
SurModics
 2.48 
 6.30 
Pulmonx
 16.55 
 1.69 
Apyx
 1.87 
 31.06 
Electromed
 2.04 
 1.00 
Lucid
 2.01 
 25.39 
Orthopediatrics
 0.07 
 15.31 
CVRx
Market Volatility
(90 Days Market Risk)
Very steady
Moderately volatile
Somewhat reliable
Very steady
Slightly risky
Very risky
Very steady
Very risky
Very steady
Somewhat reliable
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Very Weak
Very Weak
OK
Strong
OK
Very Weak
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
High
Low
Low
Quite High
Below Average
Very Low
Quite High
Low
About Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Hold
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Hold
Strong Hold
Sell
Sell
Strong Hold
Sell
Strong Sell
Hold
Current Ratio
1.0
9.86
5.32
2.04
9.43
4.45
4.83
4.55
4.75
16.82
Net Asset
132.08 M
107.65 M
326.19 M
178.56 M
177.78 M
79.24 M
52.23 M
27.27 M
438.75 M
115.23 M
Profit Margin
-2.63
-0.37
-0.16
-0.0916
-0.72
-0.58
0.0941
N/A
-0.15
-1.24
EBITDA
(87.55 M)
(22.83 M)
(45.68 M)
1.19 M
(55.09 M)
(18.11 M)
7.42 M
(49.75 M)
(8.38 M)
(43.1 M)
Operating Margin
-2.06
-0.2
-0.079
-0.0185
-0.69
-0.46
0.16
-9.98
-0.1
-0.97
Current Valuation
14.99 M
321.12 M
128.14 M
559.87 M
209.04 M
65.04 M
242.08 M
109.85 M
640.99 M
321.51 M
Price To Book
1.18
30.99
1.23
4.77
2.78
4.91
6.17
2.16
1.74
5.7
Retained Earnings
(514.3 M)
(503.81 M)
(116.95 M)
75.71 M
(411.16 M)
(54.45 M)
23.67 M
(150.74 M)
(197.74 M)
(477.38 M)
Current Asset
N/A
N/A
114.84 M
58.56 M
N/A
10.01 M
15.82 M
N/A
44 M
N/A
Beta
1.48
1.8
1.05
1.2
0.68
1.21
0.26
1.42
1.16
1.11
Number Of Employees
243
184
834
N/A
279
252
174
70
247
200
Shares Outstanding
20.76 M
29.85 M
23.82 M
14.33 M
39.49 M
37.64 M
8.46 M
55.45 M
24.22 M
24.26 M
Cash Flow From Operations
(75.37 M)
(19.7 M)
(3.23 M)
248 K
(37.61 M)
(5.25 M)
9.07 M
(32.82 M)
(27.05 M)
(39.02 M)
Total Debt
6.6 M
72.39 M
21.92 M
29.55 M
41.42 M
38.5 M
87 K
15.26 M
10.06 M
30.61 M
Return On Equity
-24.57
-2.15
-0.25
-0.0967
-0.52
-1.1
0.13
-10.08
-0.0763
-0.79
Z Score
-1.65
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.6
-0.15
-0.0966
-0.0066
-0.2
-0.22
0.0839
-1.01
-0.0394
-0.31
Number Of Shares Shorted
42.08 K
437.93 K
826.34 K
330.95 K
986.14 K
230.25 K
145.28 K
422.42 K
913.9 K
2.52 M
Book Value Per Share
2.17
0.33
7.78
8.38
2.38
0.77
5.16
-0.96
15.32
2.69
Current Liabilities
N/A
N/A
22.01 M
10.13 M
N/A
2.45 M
3.07 M
N/A
8.51 M
N/A
Total Asset
132.08 M
107.65 M
326.19 M
178.56 M
177.78 M
79.24 M
52.23 M
27.27 M
438.75 M
115.23 M
Debt To Equity
9.52
1.08
0.07
0.12
0.15
0.017
0.003
0.057
0.14
0.003
Short Ratio
1.94
2.7
3.56
1.49
4.92
5.49
2.66
0.68
6.77
4.46
Target Price
2.0
14.29
10.0
43.0
13.5
2.83
33.0
3.54
40.67
16.5
Shares Owned By Institutions
82.5
82.89
89.84
83.07
94.9
40.43
36.06
4.18
70.85
71.9
Market Capitalization
53.36 M
304.45 M
228.66 M
567.02 M
255.09 M
54.58 M
257.88 M
55.36 M
627.43 M
371.23 M
Price To Earning
N/A
N/A
61.63
69.21
N/A
4.04
23.66
N/A
-10.06
0.19
Price To Earnings To Growth
N/A
N/A
3.48
3.9
-0.42
-0.58
N/A
N/A
N/A
N/A
Price To Sales
1.3
3.98
0.69
4.5
3.22
1.11
4.71
13.21
3.31
7.86
Net Income
(108.17 M)
(32.96 M)
(102.45 M)
(11.54 M)
(60.84 M)
(18.85 M)
5.15 M
(52.67 M)
(20.97 M)
(41.2 M)
Earnings Per Share
15.0
-0.98
-2.25
-0.82
-1.47
-0.82
0.72
-1.12
-1.23
-2.69
Shares Owned By Insiders
5.42
4.1
1.78
3.79
5.16
16.18
27.7
59.09
32.52
4.39
Revenue
41.11 M
65.42 M
315.66 M
126.08 M
68.67 M
52.35 M
54.72 M
2.43 M
148.73 M
39.3 M
Working Capital
90.78 M
76.49 M
134.57 M
60.76 M
127.27 M
57.62 M
36.5 M
(7.31 M)
184.83 M
104.23 M
Cash And Equivalents
106.63 M
92.41 M
223.62 M
22.09 M
162.09 M
20.06 M
8.15 M
34.46 M
51.16 M
109.98 M
Cash Per Share
2.71
3.72
9.78
1.58
4.35
0.58
0.96
0.89
2.52
5.34
Gross Profit
14.26 M
32.49 M
153.53 M
29 M
39.87 M
29.13 M
36.52 M
(3.24 M)
90.66 M
17.47 M
Day Typical Price
4.07
10.34
9.7
39.54
6.42
1.6
30.72
0.98
25.65
15.34
Accumulation Distribution
0.0476
0.0534
4848.21
816.7
0.0555
23338.99
3250.03
0.05
0.0591
0.0776
Market Facilitation Index
0.2
0.57
0.0
0.0
0.37
0.0
0.0
0.05
1.57
1.24
Daily Balance Of Power
(0.50)
0.0877
0.0769
(0.15)
(0.43)
0.8571
0.4351
0.4
(0.33)
0.0081
Period Momentum Indicator
(0.10)
0.05
0.03
(0.04)
(0.16)
0.24
0.57
0.02
(0.52)
0.01
Rate Of Daily Change
0.98
1.0
1.0
1.0
0.98
1.17
1.02
1.02
0.98
1.0
Day Median Price
4.1
10.39
9.74
39.55
6.49
1.56
30.56
0.98
25.79
15.35
Price Action Indicator
(0.15)
(0.11)
(0.09)
(0.03)
(0.27)
0.25
0.79
0.035
(0.65)
(0.04)
Relative Strength Index
40.52
73.29
58.15
49.31
47.55
55.86
79.25
67.6
39.13
63.0
Coefficient Of Variation
(803.61)
1129.79
(816.06)
26255.65
(2,489)
1723.49
281.89
875.6
(1,233)
748.39
Mean Deviation
2.57
3.46
1.95
0.4805
3.16
3.24
2.5
2.21
2.45
3.88
Jensen Alpha
(0.34)
0.1796
(0.54)
(0.05)
(0.41)
0.1783
0.993
0.2757
(0.41)
0.7414
Total Risk Alpha
(0.91)
(0.38)
(0.88)
(0.11)
(0.87)
(0.52)
0.6176
(0.13)
(0.78)
(0.16)
Sortino Ratio
N/A
0.0976
N/A
(0.21)
N/A
0.0472
0.3606
0.0652
N/A
0.1604
Downside Variance
N/A
12.26
N/A
0.3685
N/A
12.96
7.67
8.58
N/A
18.31
Standard Deviation
3.19
5.33
3.1
0.657
4.35
5.18
3.18
2.81
3.21
6.11
Kurtosis
(0.22)
10.29
15.22
1.45
1.28
9.04
(0.20)
(0.04)
1.0
8.83
Potential Upside
4.05
9.73
3.57
1.26
8.44
9.38
6.65
5.13
4.85
10.68
Treynor Ratio
0.7464
0.1969
(0.32)
(0.02)
(0.1)
0.312
1.07
1.05
(0.23)
1.49
Maximum Drawdown
14.77
35.38
22.5
3.22
20.44
32.02
13.47
12.93
16.62
41.08
Variance
10.21
28.46
9.62
0.4317
18.94
26.79
10.13
7.92
10.33
37.35
Market Risk Adjusted Performance
0.7564
0.2069
(0.31)
(0.01)
(0.09)
0.322
1.08
1.06
(0.22)
1.5
Risk Adjusted Performance
(0.09)
0.0762
(0.09)
0.0013
(0.02)
0.0529
0.2788
0.0946
(0.05)
0.1109
Skewness
(0.02)
2.43
2.7
0.6851
0.3402
2.3
0.066
0.2701
(0.54)
2.12
Semi Deviation
N/A
3.15
N/A
0.5867
N/A
3.31
1.92
2.3
N/A
3.55
Information Ratio
(0.17)
0.0641
(0.16)
(0.19)
(0.07)
0.0328
0.3138
0.0679
(0.12)
0.1123
Value At Risk
(5.29)
(6.19)
(4.81)
(1.01)
(6.89)
(6.45)
(3.90)
(4.04)
(5.08)
(8.22)
Expected Short fall
N/A
(4.25)
N/A
(0.51)
N/A
(4.26)
(3.06)
(2.75)
N/A
(4.87)
Downside Deviation
N/A
3.5
N/A
0.607
N/A
3.6
2.77
2.93
N/A
4.28
Semi Variance
N/A
9.9
N/A
0.3442
N/A
10.95
3.69
5.31
N/A
12.6

Eargo, Competition Performance Charts

Five steps to successful analysis of Eargo, Competition

Eargo,'s competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eargo, Inc in relation to its competition. Eargo,'s competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eargo, in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eargo,'s competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eargo, Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eargo, position

In addition to having Eargo, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Thematic Idea Now

Obamacare
Obamacare Theme
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Eargo, Stock

If you are still planning to invest in Eargo, Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eargo,'s history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY